Suppr超能文献

0.05%丙酸氯倍他索洗发水对于控制中度头皮银屑病的长期疗效和安全性。

Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis.

机构信息

Centre de Recherche Dermatologique du Québec Metropolitain, Québec City, Québec, Canada.

出版信息

J Dermatolog Treat. 2010 May;21(3):185-92. doi: 10.3109/09546630903493311.

Abstract

We evaluated in this study the efficacy and safety of an alternate regimen using clobetasol propionate 0.05% shampoo (CP shampoo) for long-term control of scalp psoriasis. Patients with moderate scalp psoriasis (Global Severity Score [GSS] of 3 on a 0-5 scale) first received CP shampoo once daily for 4 weeks. Patients with a GSS <or= 2 were then randomized into the maintenance phase, receiving CP shampoo or vehicle twice weekly. When relapse (GSS > 2) occurred, patients received the 4-week daily CP shampoo treatment. Patients who had a GSS <or= 2 afterwards reinitiated the twice-weekly maintenance according to the original randomization scheme. Among the 168 patients enrolled, 141 (83.9%) had a GSS <or= 2 after the initial phase. The median time to first relapse was 141 days with CP shampoo, almost 4 months later than with vehicle (30.5 days;p < 0.0001). After 6 months, the percentage of patients who had no relapse was significantly higher with CP shampoo (40.3%) than with vehicle (11.6%;p < 0.001). CP shampoo was also safe during the 7-month study period, without leading to more cases of skin atrophy, telangiectasia, hypothalamic-pituitary-adrenal (HPA) axis suppression or adverse events compared to vehicle. The alternate treatment regimen with CP shampoo is efficacious and safe for long-term management of moderate scalp psoriasis.

摘要

我们在这项研究中评估了使用氯倍他索丙酸酯 0.05%洗发水(CP 洗发水)进行头皮银屑病长期控制的替代方案的疗效和安全性。中度头皮银屑病患者(0-5 评分制的全球严重程度评分 [GSS] 为 3)首先每天使用 CP 洗发水一次,持续 4 周。GSS <= 2 的患者随后被随机分配到维持阶段,每周接受 CP 洗发水或载体两次。当复发(GSS > 2)发生时,患者接受为期 4 周的每日 CP 洗发水治疗。此后 GSS <= 2 的患者根据原始随机分组方案重新开始每周两次的维持治疗。在纳入的 168 名患者中,141 名(83.9%)在初始阶段后 GSS <= 2。使用 CP 洗发水的首次复发中位时间为 141 天,几乎比使用载体晚 4 个月(30.5 天;p < 0.0001)。6 个月后,CP 洗发水组无复发的患者比例(40.3%)明显高于载体组(11.6%;p < 0.001)。在 7 个月的研究期间,CP 洗发水也安全,与载体相比,没有导致更多的皮肤萎缩、毛细血管扩张、下丘脑-垂体-肾上腺(HPA)轴抑制或不良事件。CP 洗发水的替代治疗方案对于中度头皮银屑病的长期管理是有效和安全的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验